Skip to main content
Screener/Healthcare/Biotechnology

AUPH — Aurinia Pharmaceuticals Inc.

NASDAQ
$16.54+0.33 (+2.04%)
Mid CapUnder $20HealthcareFastest GrowingHigh ROELow P/EMost ProfitableUndervalued
$13.33
$19.25
$16.16
$16.57
EPS (TTM)$2.07
P/E Ratio7.81
Dividend Yield—
Market Cap$2.22B
Volume530K
Prev Close$16.21
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$77.1M$210.8M$1.5389.0%273.4%
Q3 '25$73.5M$31.6M$0.2388.4%42.9%
Q2 '25$70.0M$21.5M$0.1589.8%30.7%
Q1 '25$62.5M$23.3M$0.1686.3%37.4%
Q4 '24$59.9M$1.4M$0.0190.7%2.4%
Q3 '24$67.8M$14.3M$0.1091.1%21.2%
Q2 '24$57.2M$722K$0.0184.4%1.3%
Q1 '24$50.3M-$10.7M$-0.0784.6%-21.4%
Get Your Daily Market Recap